2021
DOI: 10.3390/vaccines9050426
|View full text |Cite
|
Sign up to set email alerts
|

Balanced Cellular and Humoral Immune Responses Targeting Multiple Antigens in Adults Receiving a Quadrivalent Inactivated Influenza Vaccine

Abstract: The role of T cell immunity has been acknowledged in recent vaccine development and evaluation. We tested the humoral and cellular immune responses to Flucelvax®, a quadrivalent inactivated seasonal influenza vaccine containing two influenza A (H1N1 Singapore/GP1908/2015 IVR-180 and H3N2 North Carolina/04/2016) and two influenza B (Iowa/06/2017 and Singapore/INFTT-16-0610/2016) virus strains, using peripheral blood mononuclear cells stimulated by pools of peptides overlapping all the individual influenza viral… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7
1

Relationship

2
6

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 33 publications
0
7
0
Order By: Relevance
“…Repeated vaccination may boost antibodies to conserved epitopes and those present in egg-adapted vaccines rather than eliciting neutralizing antibodies against vaccine viruses or circulating influenza viruses [ 7 ]. Vaccine platforms that do not rely on egg-based production, including standard-dose cell culture–based inactivated influenza vaccine and recombinant-hemagglutinin (HA) protein vaccine with higher HA antigen content, may induce broader and higher immune responses to circulating influenza strains of viruses than egg-based vaccines [ 8 , 9 ]. Immune responses to annual revaccination may also differ by preexisting antibody levels, antigenic similarity between vaccine viruses in consecutive seasons, and antigen content [ 10 , 11 ].…”
mentioning
confidence: 99%
“…Repeated vaccination may boost antibodies to conserved epitopes and those present in egg-adapted vaccines rather than eliciting neutralizing antibodies against vaccine viruses or circulating influenza viruses [ 7 ]. Vaccine platforms that do not rely on egg-based production, including standard-dose cell culture–based inactivated influenza vaccine and recombinant-hemagglutinin (HA) protein vaccine with higher HA antigen content, may induce broader and higher immune responses to circulating influenza strains of viruses than egg-based vaccines [ 8 , 9 ]. Immune responses to annual revaccination may also differ by preexisting antibody levels, antigenic similarity between vaccine viruses in consecutive seasons, and antigen content [ 10 , 11 ].…”
mentioning
confidence: 99%
“…Golgi-Plug containing Brefeldin A (BD Biosciences, San Diego, CA) was added 3 h into the culture (1 μg/mL) as previously described. 73 After the incubation, cells were stained with surface markers for 30 min at 4°C followed by fixation with 4% paraformaldehyde (Sigma-Aldrich, St. Louis, MO) at 4°C for 10 min. Intracellular staining was performed at room temperature for 30 min after cells were permeabilized with saponin.…”
Section: Methodsmentioning
confidence: 99%
“…Among the TCR stimulation dependent markers, CD137 appears to be particularly interesting given its kinetics of expression after antigen recognition and its biologic role to provide a survival signal to activated T cells, both CD4+ and CD8+ T lymphocytes ( Watts, 2005 ) ( Wen et al, 2002 ). In parallel, emerging evidence are pointing to the value of assessing the cytokine profile of AIM+ T cells to better describe the intensity and features of ongoing immune response ( Painter, 2021 ; Yu et al, 2021 ; Braun et al, 2020 ).…”
Section: Introductionmentioning
confidence: 99%